Jaguar Health, Inc. (NASDAQ:JAGX) Short Interest Down 96.3% in March

Jaguar Health, Inc. (NASDAQ:JAGX) saw a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 35,700 shares, a decrease of 96.3% from the February 28th total of 953,100 shares. Based on an average daily volume of 22,800 shares, the short-interest ratio is presently 1.6 days. Currently, 0.3% of the company’s stock are short sold.

Jaguar Health Trading Up 3.5 %

JAGX stock traded up $0.18 during trading hours on Thursday, hitting $5.31. The company’s stock had a trading volume of 15,355 shares, compared to its average volume of 27,858. The stock has a 50 day moving average price of $17.15 and a two-hundred day moving average price of $23.55. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84. Jaguar Health has a 12 month low of $4.90 and a 12 month high of $540.00.

Institutional Investors Weigh In On Jaguar Health

A hedge fund recently bought a new stake in Jaguar Health stock. Virtu Financial LLC purchased a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned approximately 0.22% of Jaguar Health as of its most recent filing with the SEC. 12.04% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on Jaguar Health in a report on Thursday, March 20th. They set a “hold” rating for the company.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.